MS in the Media - 1 May 2020
25 April - 1 May 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Covid-19 outcomes for people with MS
People with MS did no worse than the general population according to preliminary results from Italy. Of 232 people with MS affected by the virus, 223 has 'mild' Covid-19 symptoms. In four people the infection was classed as severe and in six as critical. All bar 21 people were taking a disease modifying drug.
Source: The Lancet
MS Trust link: Coronavirus, Covid-19 and multiple sclerosis
Smoking and vitamin D affect cognition
People with clinically isolated syndrome (CIS) who had low vitamin D levels and who smoked were more likely to have worse cognition scores 11 years later, according to a Norwegian study
Source: Medical Xpress
MS Trust link: Smoking
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
My MS and my mental health
16 Nov 2020 - 00:00
In his latest blog, Ian Daly speaks candidly about his own experience with depression and urges others to seek help if needed.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
